Predictors of residual disease after debulking surgery in advanced stage ovarian cancer

OBJECTIVE: Optimal debulking with no macroscopic residual disease strongly predicts ovarian cancer survival. The ability to predict likelihood of optimal debulking, which may be partially dependent on tumor biology, could inform clinical decision-making regarding use of neoadjuvant chemotherapy. Thu...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbas-Aghababazadeh, Farnoosh, Sasamoto, Naoko, Townsend, Mary K., Huang, Tianyi, Terry, Kathryn L., Vitonis, Allison F., Elias, Kevin M., Poole, Elizabeth M., Hecht, Jonathan L., Tworoger, Shelley S., Fridley, Brooke L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902593/
https://www.ncbi.nlm.nih.gov/pubmed/36761962
http://dx.doi.org/10.3389/fonc.2023.1090092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902593/
https://www.ncbi.nlm.nih.gov/pubmed/36761962
http://dx.doi.org/10.3389/fonc.2023.1090092

Ejemplares similares